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ABSTRACT
Humoral and cellular immune responses communicate
with each other via Fe receptors (FeR) expressed on
various hematopoietic cells. Recent studies on several
FeR knockout mice demonstrated pivotal roles of an
IgG/FcyR system in the regulation of immune
responses and the onset of hypersensitivity. The
y subunit of FeR is an essential component of the
complex and is required for both receptor assembly
and signal transduction. FeR y chain-deficient mice
have lost the functional expression of FCERI, FcyRI, and
FcyR1I1 and are unable to mount several types of hyper-
sensitive reactions, including the skin Arthus reaction.
In contrast, FcyRII-deficient mice exhibit augmented
humoral immune responses and IgG-mediated ana-
phylaxis reactions. Thus, the regulatory system of
murine hypersensitive responses involves both positive
and negative signaling through FeR. In B cells, FcyRllb
modulates membrane Ig-induced Ca 2+ mobilization by
inhibiting Ca 2+ influx through phosphorylation of its
immunoreceptor tyrosine-based inhibition motif and
recruitment of cytoplasmic phosphatases. Elucidation
of the detailed mechanisms of negative regulatory sig-
naling in the inflammatory effector cells by FcyRllb as
well as several groups of potent inhibitory molecules
expressed on such cells should be valuable in the
development of novel therapeutic procedures for aller-
gic disorders.
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INTRODUCTION
Considerable progress has been made in the past
decade in defining the genetic organization, molecular
structures and detailed functions of Fc receptors (FcR)
using molecular biological techniques.I" In addition, a
number of strains of mice that have manipulated FcR
genes and mice with exogenous FcR genes have been
developed. These include transgenic mice strains with a
transgene for human FcyRI,6 FCERla/ human FcRy8 or
human FcyRlllA or FcyRIIIB9 and knockout mice strains
lacking a gene for mouse FcERla,lO FCERII,11-13 FcRy,14
FcyRl11S or FcyRIII.16 In particular, these gene knockout
mice have proven to be highly useful for analyzing the
physiological functions of individual FcR or its subunit
molecules in the immune system.": 18 The present review
will focus mainly on new findings and observations
derived from analysis of such gene knockout mice,
emphasizing in particular the positive and negative
regulatory functions of FcR in murine hypersensitive
responses.
STRUCTURAL FEATURES OF FcR
Most ligand-binding a subunits of FcR belong to the
immunoglobulin (Ig) superfamily and constitute a
group of complex but highly related molecules (Table 1;
Fig. 1). A total of eight genes have been identified for
the human FcyRs: three genes for the high affinity IgG
receptor FcyRI (FerRIA, FerRIB and FerRIC) 19 and five
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genes for the low affinity IgG receptors FcyR11 (FcyRI/A,
FcyRI/B and FcyRI/C)20 and FcyR111 (FcyRI/IA and
FcyRI/IB).21 The low affinity FcyR genes and the genes
for the Fc€Rla and y subunits, are clustered on chromo-
some 1q23. This region of 1q23 is syntenic to mouse
chromosome 1, where single genes for these receptors
are found. 22,23 The three FcyRI genes map to chromo-
some 1q21 . The mouse FcyRI gene has been mapped
on chromosome 3.
NOVEL FCR-RELATED MOLECULES
A receptor for IgA, FcaR, was found on the human
monocytoid cell line U93724 and on other cells, includ-
ing glomerular mesangial cells " and rnonocytes"
(Table 1; Fig. 1). A novel class of FcyR, Fcy2R, was
cloned from a cattle alveolar macrophage lib rary27 and
has the ability to bind erythrocytes sensitized with IgG2
but not IgG]. A homology search for Fcy2R indicated a
Table 1. Genes and transcripts of Fe receptors (FeR) and FeR-related molecules
Species CD Gene Chromosome" Transcripts
Human Mouse (eM)
-----
------
Human CD64 FeyRlA 1q21 FeyRla
FeyRlB 1q21 sFeyRlb 1,t FeyRlb2
FeyRlC 1q21 sFeyRle
Mouse FeyRl 3 (45.2) FeyRI
Human CD32 FeyRIIA 1q23 FeyRlla 1, sFeyRlla2
FeyRIIB 1q23 FeyRllb1, FeyRllb2, FeyRllb3
FeyRIIC 1q23 FeyRlle
Mouse FcyRII 1 (92) FeyRllb 1, FeyRllb 1I, FeyRllb2,
sFeyRllb3
Human CD16 FeyRIIIA 1q23 FeyRllla
FeyRIIIB 1q23 FeyRlllb, sFeyRlllb
Mouse FeyRIII 1 (92.3) FeyR11i
Human FeeRla 1q23 Fe£Rla
Mouse FceRla 1 (94.2) Fe£Rla
Human FeeRIf3 11q13 Fe£RI~
Mouse FeeRIf3 19 (8.0) Fe£RI~
Human FeRy 1q23 FeRy
Mouse FcRy 1 (93.3) FeRy
Human CD3' 1q22-23 CD3s, CD3T\
Mouse CD3' 1 (87.2) CD3s, CD3T\
Human CD23 FeeRlla, b 19p13.3 Fe£Rlla, sFe£RII, Fe£Rllb
Mouse FeeRII 8 (0.4) Fe£RII, sFe£RII
Human CD89 FeaR 19q13.4 FeaRa 1, FeaRa2, FeaRa3
Human poly-lgR 1q31-q41 poly-lgR
Mouse poly-lgR ? poly-lgR
Human FeRn 19q13.3 FeRn
Mouse FeRn 7 (20.0) FeRn
Human CD158 p58 KIR 19q13.4 p58 KIR
ILT 19q13.4 ILT
LAIR-l 19q13.4 LAIR-1
Mouse gp49A 10 gp49A
gp49B 10 gp49B1,gp49B2
p91A 7 p91A
p91B 7 p91B
p91C 7 p91C
*These data are available at http://www.genome.ad.jp
ts, soluble receptor.
Human
FcyRla FcyRlb2 FcyRlla FcyRllc FcyRllb
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Fig . 1 Schematic structures of human and mouse Fe receptors (FeR) and those of the associating molecules. Minor differences
omong splicing va riants within one type of FeR are not illustrated . FeRn, which pa rticipates in the transport of moternallgG in neo -
natal gut, has a structural similarity to maier histocom patibility com plex doss I molecules. Poly-Ig receptors recognize dimeric 19A
a nd polymeric 19M an d part icipate in the secretion of these mo lecules.
greater level of similarity with human Fea R than with
any other FeR." Recently, it wos reported that human
killer cell inhibitory receptors (KIR) found an natura l
killer (NK) cells as well as T cells shaw signi ficantly high
homology to humon FeaR' · (Fig. 2). The KIR are novel
members of the Ig super/amily expressed exclusivelv on
NK cells and on a subset of T cells. These molecules
playa pivota l ro le in the recogni tion of po lymorph ic
ma jor histocompatibility complex (MHC) class I mole-
cules on target cel ls and the de livery of the inhibitory
signa l to the cell inferior by mea ns of a mechanism
involving phosphorylat ion of a specific tyrosine residue
in their immunoreceptor tyrosine-based inhibitory motif
(ITIM) and recruitment of a src-homol ogy 2 (SH2)-
co nta in ing tyrosine phosphotase 1 (SHP- ] ). Natura l
killer cells in humans and mou se al so express C -type
lectin-l ike receptors , such as a CD94/NKG 2A com plex
in humans and a Ly-49 dimer in the mouse. Recent
data have indicated that gp49B , a type I transmem-
brane glycoprotein belonging to the Ig super/amily
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Fig . 2 Schematic structures of huma n and mouse immunoreceptor tvrosine-bosed inhibitory motif (ITIM)- o r ITIM -like sequence-
contain ing mol ecu les expressed on various hematopo ietic cells. Ligand, cell types and associating mo lecules to intracellu lar ITIM or
ITIM·like moti fs o re shown in cases where they are known.
expressed o n murine NK ce lls and ma st ce lls, fun ctions
as an inhibita ry malecu le on these cells.'9-3\ Thus,
both human ond mouse NK cells express lq -relo ted
inhibitory receptors, in additio n to C ·type lectin- like
malecules (Fig. 2).
Interestingly, several g roups, includ ing our own, have
cloned navel KIR-like inhibitory molecules fram mouse and
humans expressed on various hematopoietic cells, such as
B cells, macrophages and masl cells. They are murine
p91A 31.33 or poired inhibilory receptor-B (PIR-B)" and
human immunoglobulin-like transcripts (ILT)3S·' · and
leukocyte-associated immu noglobu lin-like receptor- 1
(LAIR- l)37 (Fig. 2). They have one or a set of Ig-like extro-
cellular domains, a transmembrane region and a cyto-
plasmic portion containing ITIM-like sequences. Although
the physiolog ical ligands for these receptars are not known,
these malecules have been shown to be inhibitory to cell
od ivation,36,37 recruiting cytoplasmic phosphatases to the
rvrostne-chospborvloted cyloplasmic motifs in a similar
fashion to that of human KIR. Chramosomal locations of
the human p58 KIR, FcaR, lAIR- J and ILT have been
mapped within 19q 13.4. The genes for humon KIR ond
murine KIR-like molecules, humon Fca Rand bovine Fcy2R
may have evolved from a common ancesto r.
PIVOTAL ROLES OF FeR IN STIMULATIO N O F
HYPERSENSITIVE RESPO NSES
Mast cells and bosoph ils ploy a prominent role in
anaphylaxis following activation by IgE and allergen .
These cells of mou se origin express at least three types af
receptors for IgE: Fc£RI, FcyRl1and Fcy Rll1. Fc£RI binds
mo no meric IgE, whereas the two low affinity IgG recep-
tors bind both IgG ond IgE immune co mplexes." To
eva luate the relative co ntribution of these IgE recepto rs to
the genesis of in vivo anaphylaxis, Dombrowicz et 0/. 10
have generated Fc£Rla·defic ienl mice. Immunoglobulin
E-med iated cutaneous and system ic anaph ylaxis were
tested in these mice. They in jected mice with m urine anti -
dinitraphen yl (ONP) IgE inta the ear or intravenausly (i.v.)
and then challenged mice with i.v. injections of antigen.
The deposilian of fibrin in the injected ear of mice or
rectoI temperature was measured as on index of the
severity of passive cutaneous anophylaxis (PCA) or of
systemic anaphylaxis , respectively. The Fc£Rla-deficient
mice were resistant to cutaneo us and systemic an aphy -
laxis Iriggered by IgE, verifying thai Fc£RI is essenl ial for
the onsel of IgE.dependent anaph ylaxis.
Initially identified as a subunit of Fc£RI, FcRy is also a
subunit of the FcyRI and, in a subset of T cells, functions
as a subunit of the T cell receptor (TCR) cornplex" 43 It is
also critical for transducing signals into the cell interior,
which results in cellular octivctiorr'v" through tyrosine
kinase Lyn- and Syk-activation pathways, mediated by
the immunoreceptor tyrosine-based activation motif
{ITAM).46 Takai et 01. 14 have generated a mouse strain
genetically deficient in FcRy. The ablation of this chain
resulted in the almost complete loss of effector responses,
such as antibody dependent cell-mediated cytotoxicity by
NK cells, phagocytosis of IgG-opsonized particles by
macrophages and IgE-dependent degranulation due to
the loss of FcyRI, FcyR111 and FCERI on these cells.
FcRy-deficient mice did not respond to various exper-
imental induction protocols of inflammatory reac-
tions. 14,47,48 For example, bone marrow-derived cultured
mast cells isolated from FcRy-deficient mice lack IgE
binding, as a result of the loss of FCERI.14 Consistent with
the loss of these in vitro mast cell functions, PCA reaction
mediated via FCERI and IgE on mast cells in vivo was
ablated in the FcRy-deficient rnice.!" agreeing with the
observations from FCERla-deficient mice described
earlier. 10
Mast cells and basophils can be activated in vitro and
in vivo by non-lgE stimuli."? Oettgen et 01. 50 have
reported that IgE knockout mice were able to mount sys-
temic anaphylaxis at a similar magnitude to that of
wild-type mice on antigen challenge, suggesting that the
type I hypersensitivity reaction is inducible upon crosslink-
ing between FcyRll/ll1 on mast cells by IgG immune
complexes as well as crosslinking of FCERI via IgE and
antigen, in agreement with the phenotypes of FcyRllb-
deficient mice 15 described later.
FcRy-deficient mice were shown to be resistant to the
development of experimental autoimmune hemolytic
anemia induced by rabbit anti-mouse red blood cell IgG
ontibodies.:" This resistance was primarily a consequence
of ineffective erythrophagocytosis, resulting from the lack
of FcyR on phagocytes. Therefore, it was suggested that
FcRplay an important role in the pathogenesis of antibody
induced type II hvpersensitivitv."
The type III hypersensitivity response is caused by the
deposition of an immune complex. As an experimental
model of this type of response, one injects antibody into
the skin and administers the antigen i.v. followed by
assessment of skin inflammation, such as edema, hem-
orrhage and neutrophil infiltration after 2-24 h (reverse
passive Arthus reaction). This induction scheme is
interpreted as the local formation of immune complex,
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complement activation via the classical pathway and
triggering of the inflammatory cascade. Sylvestre and
Rovetch:" re-evaluated this cascade using FcRy-deficient
mice and found that the Arthus reaction is not able to be
induced without FcyR. Mice were injected i.v. with oval-
bumin (OVA) and then given i.d. injections of anti-OVA
IgG. The FcRy knockout mouse showed a distinct reduc-
tion in edema, hemorrhage and neutrophil infiltration.
Therefore, the inflammatory deficit observed in the
mutant mice can be attributed to the lack of FcR in these
onimols.t" Sylvestre et a/. then examined the Arthus reac-
tion in complement-deficient mice and found that the
magnitude of the reaction was comparable to that of
wild-type cnimols.v' confirming that the complement
system is not essential and that FcyR are the primary ini-
tiators of the Arthus reaction in the skin. Using differen-
tial reconstitution of the mast cell-deficient mouse strain
WIWv with mast cells derived from wild-type or FcRy-
deficient mice, Sylvestre and Ravetch52 further demon-
strated that the Arthus reaction in FcRy-deficient mice
was shown to be reconstituted by such mast-cell transfer.
Therefore, it was confirmed that the tissue mast cells
from FcRy-deficient mice are primary candidates of this
unresponsiveness to type III hypersensitivity induced in
skin and the effector molecule that is responsible for the
initiation of this type of reaction is FcyR111. This notion
has been verified using FcyRllla-deficient mice gener-
ated by Hazenbos et 01. 16 Strikingly, the mice exhibited
an impaired Arthus reaction. These data support the
notion that FcyR111 playa dominant role in the type III
hypersensitive response induced in the skin.
NEGATIVE IMMUNE REGULATION BY FCGRIIB
Negative signaling through FcyRllb
FcyRllb is unique among other FcR, both structurally and
functionally. This receptor molecule does not associate with
an FcRyhomodimer and possesses an ITIM.53 When B cells
are stimulated with anti-Ig F{ab'h, the cells proliferate effi-
ciently due to crosslinking of surface Ig, but intact anti-Ig
antibody fails to do so. This phenomenon has been inter-
preted as indicating that FcyRllb molecules on B cells bind
the Fc portion of the antibody and form co-crosslinkages
between the antigen receptor and FcyRllb via an anti-Ig
antibody. This observation suggests that FcyRllb on B cells
may inhibit antibody production in immune response in
vivo.54 Amigorena et 01. 55 and Muta et 01. 56 transfected
FcyRll-deficient A20 B lymphoma cell line, IIA1.6, with
FcyRllb and observed that anti-Ig antibody that crosslinks
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surface FcyRllbwith membrane Ig inhibits Ca2+ mobilization
in that cell line. It was shown that FcyR.llb modulates mem-
brane Ig-induced Ca 2+ mobilization by inhibiting Ca 2+
influx without changing the pattern of tyrosine phosphory-
lation. 56,57 The 13 amino acid sequence including ITIM in
the cytoplasmic domain of FcyRllb was both necesscrv'"
and sufficient56for this effect. The inhibitory motif in FcyRllb
controls B cell activation by inhibiting a Ca 2+ signaling
pathway triggered through ITAM of Ig-a and Ig-~ as a result
of recruitment of novel SH2-containing proteins that interact
with the tyrosine-phosphorylated ITIM.56 Cambier et 01. 58
showed one of the SH2-containing proteins as a cytoplas-
mic protein tyrosine phosphatase, SHP-1. Daeron et a/. 53
have reported that the inhibition signaling through FcyRllb
is a more general mechanism of immunosuppression in a
variety of cells, including B cells, T cells and mast cells,
showing that FcyRllb inhibit Fc£RI- and T cell receptor-
dependent cell activation as well as B cell receptor
pathways. Recently, Ono et a/. 59 have shown that the
inhibitory signaling by FcyRllb does not require SHP-1 in
mast cells and results in the recruitment of the SH2-domain-
containing inositol polyphosphate 5-phosphatase, SHIp'60
to the tyrosine-phosphorylated 13-amino-acid inhibitory
motif of FcyRllb in both B cells and mast cells. Furthermore,
Ono et 01. 61 have generated SHP-1- or SHIP-deficient B cell
lines to determine their ability to mediate inhibitory signal-
ing. They found that two distinct classes of inhibitory
responses are defined. The FcyR11 class of inhibitory signal-
ing is dependent on SHIP. In contrast, KIR requires SHP- 1 for
its inhibitory signaling.
Enhanced hypersensitive responses in FcyRII-
deficient mice
Crosslinking stimulation of surface IgM on splenic B cells
using intact anti-lllgG resulted in the marked proliferative
response in B cells from FcyRII-deficient mice but not in
those cells from wild-type mice, confirming the role of
FcyRllb on B cells as a negative regulator of signaling
through the antigen receptor in vitro. 15 The FcyRIl-deficient
mice showed higher antibody titers than those of wild-type
mice when they were immunized with T-dependent as well
as T-independent antigens. The number of anti-sheep
erythrocyte IgM and IgG plaque-forming cells in spleno-
cytes from FcyRII-deficient mice were higher than those of
wild-type mice, especially in the secondary immune
response. Therefore, it was shown that FcyRllb negatively
regulates antibody production in ViVO. 15
Bone marrow-derived cultured mast cells from FcyR.ll-
deficient mice were stimulated by crosslinking Fc£RI with
IgE and anti-lgE or FcyRII/1I1 with anti-FcyRII/11i mono-
clonal antibody 2.4G2 and anti-rat IgG and their
degranulation was estimated in vitro. 15 Interestingly, al-
though mast cells from wild-type mice did not degranulate
upon crosslinking of surface FcyRllb and FcyR11i with
2.4G2 and anti-rat IgG, mast cells from the mutant
animals responded significantly on the same crosslinking
stimulus. In vitro observations by Daeron et 01. 49 ,53 are con-
sistent with these data. Immunoglobulin G-induced PCA
reactions in FcyRII-deficient mice were augmented several-
fold over those in wild-type mice.l ' These observations in
FcyRII-deficient mice provide an indication of the mecha-
nism responsible for the onset of hypersensitive responses.
It is clear that IgE antibody works very efficiently as a trig-
gering molecule through its binding to the high-affinity
receptor for IgE, Fc£RI, on immune cells such as mast cells
and basophils. Similarly, the IgG immune complex-
induced positive switching through FcyR111 is also present,
but is attenuated in normal situations because FcyRllb is
co-expressed simultaneously with FcyR111 on most effector
cells and this receptor delivers abortive or negative signal-
ing upon co-engagement with FcyR111. In FcyRIl-deficient
mice this negative switching does not operate so that the
FcyRIII-mediated signaling cascade will work effectively.
FCERII DELETION
Fc£RII-deficient mouse lines have been generated inde-
pendently by three groupS.11-13 In the case of mice
generated by Yu et 01.,11 immunization with T-dependent
antigens in alum adjuvant with Bordetella pertussis leads
to increased and sustained specific IgE and IgG1antibody
titers compared with controls. These authors proposed
that murine Fc£RII possibly acts as a negative feedback
component of IgE requlotion.!' In contrast, a Fc£RII-
deficient mouse generated by Fujiwara et 01. 13 displayed
normal lymphocyte differentiation and could mount
normal antibody responses, including IgE responses, fol-
lowing immunization with T-dependent antigens in
complete Freund's adjuvant. The inconsistency may arise
from differences in the genetic background of mice and
differences in the immunization protocol.
CONCLUDING REMARKS
Recent advances in understanding the regulatory mecha-
nisms of FcR on murine hypersensitive responses are
due to various reasonable results that are consistent with
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Fig .3 A hypothetica l model for the regulation of hypersensitive respo nses byFe recep tors (FeR) . Th1 and Th2 induce cellu lar and
humora l immune respons es, respectively. These two processes ore cross-regu lated by cytok ines, antibodi es and FeR. This hypotheti-
cal model po stulates that deregu lation by FeR cou ld be an importa nt factor for the onset of hypersensitivity.
preceding in vitro data as well as to unexpected obser-
vations in FcR-deficient mice. Using FcRr-, Fc£Rla- or
FcyRllla-deficient mice, the mechan isms of initiating
several types of hypersensitivity cascades have been re-
evoluated. It has been shawn that the bindi ng of IgE to
Fc£RI and the binding of the IgG immune com plex to
FcyRll1 on effector cells are pivotal events that lead to IgE-
induced anaph ylaxis and the IgG -induced skin Arthus
reaction, respective ly. In con trast, it has been pro posed
that suppression of these activation events through FcyRIlb
could be a potent means of maintain ing homeostasis and
controlling inap propriate effector cell activation (Fig. 3).
Elucidation of bioch emical nature of the inhib itory cas-
codes, as well as detailed physiological roles of Fcy RI lb
ond novel mo lecular famili es, such os gp49B, p9 1A/
PIR-B, ILT and LAIR- l, will be cholle nging fields in the next
several years.
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